Jukka Westermarck

23PUBLICATIONS
95CO-AUTHORS
Molecular targetsPredictive and prognostic markersMolecular imaging (incl. electron microscopy and neutron diffraction)Cancer diagnosisNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Sep 07, 2026
Activation of PP2A-B56a leads to aberrant EGFR signaling and proliferative phenotypes in PDAC.

|Jul 17, 2025
LIMA1-alpha staining predicts curative intent surgery response in HPV negative head and neck cancer.

Xi Qiao, Johannes Routila, Mari Tienhaara

|Jun 05, 2025
NRF2-mediated persistent adaptation of oesophageal adenocarcinoma cells to HER2 inhibition.

Wei Zhang, Jiaqing Lang, Sorayut Chattrakarn

|Jul 18, 2024
The PP2A regulator IER5L supports prostate cancer progression.

Jana R Crespo, Natalia Martín-Martín, Saioa Garcia-Longarte

|Jun 17, 2024
DUSP6 inhibition overcomes neuregulin/HER3-driven therapy tolerance in HER2+ breast cancer.

Majid Momeny, Mari Tienhaara, Mukund Sharma

|Jul 17, 2023
PP2A-based triple-strike therapy overcomes mitochondrial apoptosis resistance in brain cancer cells.

Oxana V Denisova, Joni Merisaari, Riikka Huhtaniemi

Pageof 4

Frequent Collaborators

3 joint publications

Mukund Sharma

2 joint publications

Saioa Garcia-Longarte

2 joint publications

Roger R Gomis

2 joint publications

Arkaitz Carracedo